[HTML][HTML] SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer

C Li, X Peng, J Lv, H Zou, J Liu, K Zhang, Z Li - Biomedicine & …, 2020 - Elsevier
Background SREBP1 is a well-known transcript factor regulating lipogenesis. It has been
reported to play an important role in tumor progress in recent years. However, the roles of …

SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer.

C Li, X Peng, J Lv, H Zou, J Liu, K Zhang… - Biomedicine & …, 2019 - europepmc.org
Background SREBP1 is a well-known transcript factor regulating lipogenesis. It has been
reported to play an important role in tumor progress in recent years. However, the roles of …

SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer

C Li, X Peng, J Lv, H Zou, J Liu… - Biomedicine & …, 2020 - pubmed.ncbi.nlm.nih.gov
Background SREBP1 is a well-known transcript factor regulating lipogenesis. It has been
reported to play an important role in tumor progress in recent years. However, the roles of …

[引用][C] SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer

C Li, X Peng, J Lv, H Zou, J Liu, K Zhang… - Biomedicine & …, 2020 - cir.nii.ac.jp
SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid
cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …